Literature DB >> 2895350

Will antibody-dependent enhancement of HIV-1 infection be a problem with AIDS vaccines?

W E Robinson, D C Montefiori, W M Mitchell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2895350     DOI： 10.1016/s0140-6736(88)91695-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Two immunodominant domains of gp41 bind antibodies which enhance human immunodeficiency virus type 1 infection in vitro.

Authors:  W E Robinson; M K Gorny; J Y Xu; W M Mitchell; S Zolla-Pazner
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

2.  Antibody-dependent enhancement of human immunodeficiency virus type 1 (HIV-1) infection in vitro by serum from HIV-1-infected and passively immunized chimpanzees.

Authors:  W E Robinson; D C Montefiori; W M Mitchell; A M Prince; H J Alter; G R Dreesman; J W Eichberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

3.  Antibodies to the primary immunodominant domain of human immunodeficiency virus type 1 (HIV-1) glycoprotein gp41 enhance HIV-1 infection in vitro.

Authors:  W E Robinson; T Kawamura; D Lake; Y Masuho; W M Mitchell; E M Hersh
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

4.  Lack of enhancing effect of human anti-human immunodeficiency virus type 1 (HIV-1) antibody on HIV-1 infection of human blood monocytes and peritoneal macrophages.

Authors:  P P Shadduck; J B Weinberg; A F Haney; J A Bartlett; A J Langlois; D P Bolognesi; T J Matthews
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

5.  Antibody-dependent enhancement of simian immunodeficiency virus (SIV) infection in vitro by plasma from SIV-infected rhesus macaques.

Authors:  D C Montefiori; W E Robinson; V M Hirsch; A Modliszewski; W M Mitchell; P R Johnson
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

6.  Complement-mediated, infection-enhancing antibodies in plasma from vaccinated macaques before and after inoculation with live simian immunodeficiency virus.

Authors:  D C Montefiori; M Murphey-Corb; R C Desrosiers; M D Daniel
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

7.  A study of human respiratory tract chlamydial infections in Cambridgeshire 1986-88.

Authors:  T G Wreghitt; C E Barker; J D Treharne; J M Phipps; V Robinson; R B Buttery
Journal:  Epidemiol Infect       Date:  1990-06       Impact factor: 2.451

8.  Human monoclonal antibodies to the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein gp41 enhance HIV-1 infection in vitro.

Authors:  W E Robinson; T Kawamura; M K Gorny; D Lake; J Y Xu; Y Matsumoto; T Sugano; Y Masuho; W M Mitchell; E Hersh
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.